News

The United Nations launched this initiative in 2015 to promote gender equality in STEM, an opportunity to support and include women and girls in order for them to receive full and equal access to careers in science.

There are over 50 million people living with epilepsy and over 50% of them will experience some kind of stigma surrounding the illness.

Angelini Pharma has been awarded the prestigious Top Employer certification for the sixth consecutive year.

LIFE-GREENAPI: Innovating for the Future is the title of the event hosted by Angelini Pharma at its Fine Chemicals plant in Aprilia.

Rafal Kaminski contributes an op-ed to Labiotech in which he presents an overview of the current treatment landscape for people living with epilepsy.

Initiated by the European Commission and funded by the Marie Sklodowska Curie Actions (MSCA), European Researchers' Night is the largest science outreach and research event in Europe.

Jacopo Andreose advocates for increased European investment in Mental Health, highlighting its societal and economic benefits in an Op-Ed for Euroactiv.

Launched by the WHO in 2019, World Patient Safety Day is observed annually on 17th September in recognition of patient safety as a large and growing public healthcare challenge.

Organised by the International League Against Epilepsy (ILAE) and held biennially between 7th and 11th September, Angelini Pharma is proud to announce its participation in the 15th EEC.

Brain health and sex and gender differences represent a crucial and innovative area of study in modern medicine.